company background image
WINDLAS logo

Windlas Biotech NSEI:WINDLAS Stock Report

Last Price

₹1.01k

Market Cap

₹21.1b

7D

1.9%

1Y

111.3%

Updated

18 Jan, 2025

Data

Company Financials

Windlas Biotech Limited

NSEI:WINDLAS Stock Report

Market Cap: ₹21.1b

WINDLAS Stock Overview

A contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. More details

WINDLAS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Windlas Biotech Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Windlas Biotech
Historical stock prices
Current Share Price₹1,007.30
52 Week High₹1,198.25
52 Week Low₹452.55
Beta0.38
1 Month Change-1.75%
3 Month Change-1.31%
1 Year Change111.28%
3 Year Change271.29%
5 Year Changen/a
Change since IPO147.40%

Recent News & Updates

There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Nov 20
There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Recent updates

There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Nov 20
There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Nov 01
Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Sep 01
Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 13
Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Jul 30
Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Jun 07
Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03
Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20
Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23
Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07
Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Shareholder Returns

WINDLASIN Life SciencesIN Market
7D1.9%1.1%-0.3%
1Y111.3%49.7%10.8%

Return vs Industry: WINDLAS exceeded the Indian Life Sciences industry which returned 49.7% over the past year.

Return vs Market: WINDLAS exceeded the Indian Market which returned 10.8% over the past year.

Price Volatility

Is WINDLAS's price volatile compared to industry and market?
WINDLAS volatility
WINDLAS Average Weekly Movement7.7%
Life Sciences Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.2%

Stable Share Price: WINDLAS's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: WINDLAS's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
20011,154Komal Guptawindlas.com

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products.

Windlas Biotech Limited Fundamentals Summary

How do Windlas Biotech's earnings and revenue compare to its market cap?
WINDLAS fundamental statistics
Market cap₹21.05b
Earnings (TTM)₹612.28m
Revenue (TTM)₹6.96b

34.4x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WINDLAS income statement (TTM)
Revenue₹6.96b
Cost of Revenue₹4.39b
Gross Profit₹2.57b
Other Expenses₹1.96b
Earnings₹612.28m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)29.30
Gross Margin36.91%
Net Profit Margin8.80%
Debt/Equity Ratio3.2%

How did WINDLAS perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

19%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 23:05
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Windlas Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution